Literature DB >> 11572174

[From gene to disease; neurofibromatosis type 1].

A de Goede-Bolder1, M H Cnossen, D Dooijes, A M van den Ouweland, M F Niermeijer.   

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant disease characterised by café-au-lait spots, freckling in the axillary or inguinal region, dermal and plexiform neurofibromas and Lisch nodules. Complications are severe in one third of patients, and the clinical variability is pronounced, even within families. The NF1 gene has been localised to chromosome 17q11.2 and encodes the protein neurofibromin. The gene is proposed to be a tumour suppressor gene. Inactivation of neurofibromin leads to a disruption in cell growth regulation. Mutation analysis is possible but laborious, and therefore NF1 is generally a clinical diagnosis based on diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572174

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Neurofibromatosis type 1: a single center's experience in Korea.

Authors:  Min Jeong Kim; Chong Kun Cheon
Journal:  Korean J Pediatr       Date:  2014-09-30

2.  Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study.

Authors:  Johanna M Meulepas; Cécile M Ronckers; Anne M J B Smets; Rutger A J Nievelstein; Andreas Jahnen; Choonsik Lee; Mariëtte Kieft; Johan S Laméris; Marcel van Herk; Marcel J W Greuter; Cécile R L P N Jeukens; Marcel van Straten; Otto Visser; Flora E van Leeuwen; Michael Hauptmann
Journal:  Eur J Epidemiol       Date:  2014-04-19       Impact factor: 8.082

3.  Novel mutations in one allele in a Chinese family with neurofibromatosis type 1: Including a complex insertion-deletion mutation.

Authors:  Lude Zhu; Lei Shi; Bo Wang; Mingye Bi; Jie Pu; Linglin Zhang; Yunfeng Zhang; Xiuli Wang; Guolong Zhang
Journal:  J Dermatol       Date:  2016-07-04       Impact factor: 4.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.